Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Dose on Motor Evoked Potentials During Spine Surgery
NCT03378973Phase 4Terminated
- Sponsor
- Hospital for Special Surgery
- Start
- Nov 2018
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine in spinal fusion, sponsored by Hospital for Special Surgery. Started Nov 2018; status: terminated.
02
Drugs
dexmedetomidine
03
Conditions
spinal fusion
Beyond the preview
Go deeper on NCT03378973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03378973.